Chemotherapy for osteosarcoma without high-dose methotrexate: Another piece in the puzzle

被引：12
|
作者：
Blay, Jean-Yves
机构：
[1] Hop Edouard Herriot, F-69003 Lyon, France
[2] Ctr Leon Berard, INSERM, U590, F-69373 Lyon, France
来源：
ONKOLOGIE | 2007年 / 30卷 / 05期
关键词：
D O I：
10.1159/000101702
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：226 / 227
页数：2
相关论文
共 50 条
  • [21] THE UNCLEAR ROLE OF HIGH-DOSE METHOTREXATE IN ADULT OSTEOSARCOMA (OS)
    RICHARDS, JM
    VOGELZANG, NJ
    SIMON, M
    CLINICAL RESEARCH, 1986, 34 (04): : A932 - A932
  • [22] Pharmacogenetic analysis of high-dose methotrexate treatment in paediatric osteosarcoma
    Hegyi, M.
    Csordas, K.
    Eipel, O.
    Csagoly, E.
    Erdelyi, D. J.
    Semsei, A. F.
    Kovacs, G. T.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S353 - S353
  • [23] Outcomes of Osteosarcoma in Children Without High-Dose Methotrexate: Could It Be Less Toxic Without Effecting Survival Rates?
    Eker, Nursah
    Tokuc, Ayse G.
    Yilmaz, Baris
    Aktas, Zeynep
    Bugdayci, Onur
    Erol, Bulent
    Senay, Emel
    Aras, Seda
    JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY, 2022, 11 (03) : 252 - 258
  • [24] SARCOIDOSIS FOLLOWING ADJUVANT HIGH-DOSE METHOTREXATE THERAPY FOR OSTEOSARCOMA
    SYBERT, A
    BUTLER, TP
    ARCHIVES OF INTERNAL MEDICINE, 1978, 138 (03) : 488 - 489
  • [25] Pharmacogenetic analysis of high-dose methotrexate treatment in children with osteosarcoma
    Hegyi, Marta
    Arany, Adam
    Semsei, Agnes F.
    Csordas, Katalin
    Eipel, Oliver
    Gezsi, Andras
    Kutszegi, Nora
    Csoka, Monika
    Muller, Judit
    Erdelyi, Daniel J.
    Antal, Peter
    Szalai, Csaba
    Kovacs, Gabor T.
    ONCOTARGET, 2017, 8 (06) : 9388 - 9398
  • [26] PLASMA AND CSF METHOTREXATE LEVELS DURING HIGH-DOSE METHOTREXATE CHEMOTHERAPY
    GILCHRIST, NL
    CALDWELL, J
    WATSON, ID
    CUNNINGHAM, D
    FORREST, GJ
    SOUKOP, M
    BRITISH JOURNAL OF CANCER, 1985, 51 (04) : 590 - 590
  • [27] Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
    Barbara Rossi
    Giovanni Schinzari
    Giulio Maccauro
    Laura Scaramuzzo
    Diego Signorelli
    Michele A Rosa
    Carlo Fabbriciani
    Barone Carlo
    BMC Musculoskeletal Disorders, 11
  • [28] A survival analysis and treatment outcomes of 131 cases of osteosarcoma treated with high-dose methotrexate multidrug chemotherapy
    Xu, Ye-Feng
    Jiang, Shen-Jun
    Wang, Yi-Qing
    Yao, Yong-Wei
    Liu, Yun-Xia
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (05): : 8465 - 8473
  • [29] Ifosfamide/etoposide alternating with high-dose methotrexate: evaluation of a chemotherapy regimen for poor-risk osteosarcoma
    M P Michelagnoli
    I J Lewis
    H R Gattamaneni
    C C Bailey
    L S Lashford
    British Journal of Cancer, 1999, 79 : 1174 - 1178
  • [30] Neoadjuvant multidrug chemotherapy including High-Dose Methotrexate modifies VEGF expression in Osteosarcoma: an immunohistochemical analysis
    Rossi, Barbara
    Schinzari, Giovanni
    Maccauro, Giulio
    Scaramuzzo, Laura
    Signorelli, Diego
    Rosa, Michele A.
    Fabbriciani, Carlo
    Carlo, Barone
    BMC MUSCULOSKELETAL DISORDERS, 2010, 11
12345